Employment
-
Rhizen Pharmaceuticals SA2013 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (11)
- A first‐in‐human study to evaluate the safety, tolerability and pharmacokinetics of RP3128, an oral calcium release‐activated calcium (CRAC) channel modulator in healthy volunteers Save
- Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma. Save
- Observations on healthcare workers & SARS-CoV-2 infection. Save
- A First-in-human Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study. Save
- Evaluation of the estrogenic activity of Indian medicinal plants in immature rats. Save
- A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine. Save
- What to use to express the variability of data: Standard deviation or standard error of mean? Save
- Diphtheria, tetanus, and pertussis immunity in Indian adults and immunogenicity of td vaccine. Save
- Immunogenicity of two diphtheria-tetanus-whole cell pertussis-hepatitis B vaccines in infants: a comparative trial. Save
- A pandemic influenza vaccine in India: from strain to sale within 12 months. Save